Clin2
NCT07098663Worth exploringRecruiting

Study of MKP10241 for weight loss and diabetes control

Type 2 Diabetes Mellitus (T2DM)Food EffectSafety and TolerabilityObesity

Part of Hormones & metabolism clinical trials.

This study tests an investigational drug called MKP10241 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects blood sugar, weight, and overall safety. It may be an option if you have obesity or type 2 diabetes managed by diet and/or metformin.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
68 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You are either a healthy volunteer (BMI 18–30) or have obesity (BMI 32 or higher) and possibly type 2 diabetes.
  • If you have diabetes, your blood sugar (fasting) must be between 125 and 260 mg/dL, and your diabetes must be managed by diet/exercise or a stable dose of metformin.
  • You must not smoke more than 5 cigarettes a day and agree not to drink alcohol for 48 hours before dosing until the end of the study.
  • You must be willing to stay at the study clinic for periods of time and follow all study rules.
  • You cannot have a history of seizures, major surgery within the past 2 months, or certain liver, kidney, or heart problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06700538Recruiting· Phase 1/Phase 2
Study of an experimental drug for obesity with or without type 2 diabetes

This study tests an experimental medication called ARO-INHBE in adults with obesity, including those who also have type 2 diabetes. The goal is to see if it helps with weight loss and is safe.

Camberwell
NCT07533175Recruiting· Phase 3
Testing a new weight-loss medicine for type 2 diabetes

This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.

Birmingham, Alabama
NCT07578584Recruiting· Phase 1
Safety study of NNC0497-0040 in healthy and overweight adults

This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.

Neuss
NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.